Natrii Fluoridum (18f) Synektik (Sodium Fluoride (18f))

Sodium fluoride, the active ingredient in Natrii Fluoridum (18f) Synektik, is a fluoride presented as an intravenous solution for systemic use. It is employed in the prevention of dental caries and in the treatment of fluoride deficiency, particularly in patients at risk of enamel demineralisation.

GNH USA supplies Natrii Fluoridum (18f) Synektik as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to strict quality standards and provides reliable logistics for global distribution efficiently.

Natrii Fluoridum (Sodium Fluoride) acts within the fluoride therapeutic class to address conditions related to mineral loss in teeth. - Dental caries: reduces incidence of new carious lesions by enhancing enamel resistance. - Fluoride deficiency: restores systemic fluoride levels to support normal enamel formation. - Enamel demineralization: promotes remineralization of early enamel lesions and strengthens existing tooth structure.

Adverse reactions may occur with systemic fluoride administration.

Common Side Effects: - Nausea: mild to moderate discomfort in the stomach. - Vomiting: occasional expulsion of gastric contents. - Abdominal pain: cramping or discomfort in the abdomen. - Metallic taste: transient alteration in taste perception. - Headache: mild to moderate head pain. - Dizziness: sensation of light‑headedness or unsteadiness.

Serious or Rare Side Effects: - Fluorosis: excessive fluoride leading to enamel discoloration or skeletal changes. - Hypocalcemia: low blood calcium levels causing muscle spasms. - Cardiac arrhythmia: irregular heart rhythm potentially life‑threatening. - Severe allergic reaction: including anaphylaxis with rash, swelling, and breathing difficulty. - Seizures: convulsive episodes in cases of acute toxicity.

When using Natrii Fluoridum, consider the following precautions. - Assess fluoride status: evaluate baseline serum fluoride before initiating therapy. - Monitor serum levels: periodic testing recommended during prolonged treatment. - Renal impairment: adjust use in patients with reduced kidney function. - Hypersensitivity: avoid in individuals with known allergy to fluoride compounds. - Pregnancy and lactation: safety not established; weigh risks and benefits. - Store at room temperature: keep in original container, protect from light and moisture.

Potential drug interactions should be reviewed before administration.

Major Interactions (Avoid): - Calcium‑containing antacids: may bind fluoride and reduce efficacy. - Aluminum hydroxide: forms insoluble complexes with fluoride. - Magnesium hydroxide: decreases fluoride absorption.

Moderate Interactions (Monitor Closely): - NSAIDs: combined renal effects may increase risk of kidney injury. - Diuretics: may alter electrolyte balance affecting fluoride handling. - ACE inhibitors: potential additive impact on renal function.